Report overview
The field of microfluidics uses microfabrication to create miniaturized devices to handle fluids. The field of microfluidics has four parents: molecular analysis, biodefence, molecular biology and microelectronics. Advances in microfluidics technology are revolutionizing molecular biology procedures for enzymatic analysis (glucose and lactate assays), DNA analysis (polymerase chain reaction and high-throughput sequencing), and proteomics.
This report aims to provide a comprehensive presentation of the global market for Healthcare Microfluidics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Healthcare Microfluidics. This report contains market size and forecasts of Healthcare Microfluidics in global, including the following market information:
Global Healthcare Microfluidics Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Healthcare Microfluidics Market Sales, 2018-2023, 2024-2029, (Units)
Global top five Healthcare Microfluidics companies in 2022 (%)
The global Healthcare Microfluidics market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Glass Based Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Healthcare Microfluidics include Abbott Laboratories, Agilent Technologies, Inc., BD, Bio-Rad Laboratories, Danaher Corporation, Roche, IDEX Corporation, PerkinElmer and Thermo Fisher Scientific, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Healthcare Microfluidics manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Healthcare Microfluidics Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Healthcare Microfluidics Market Segment Percentages, by Type, 2022 (%)
Glass Based
Polymer Based
Silicon Based
Others
Global Healthcare Microfluidics Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Healthcare Microfluidics Market Segment Percentages, by Application, 2022 (%)
Homecare
Hospitals
Others
Global Healthcare Microfluidics Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Healthcare Microfluidics Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Healthcare Microfluidics revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Healthcare Microfluidics revenues share in global market, 2022 (%)
Key companies Healthcare Microfluidics sales in global market, 2018-2023 (Estimated), (Units)
Key companies Healthcare Microfluidics sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott Laboratories
Agilent Technologies, Inc.
BD
Bio-Rad Laboratories
Danaher Corporation
Roche
IDEX Corporation
PerkinElmer
Thermo Fisher Scientific
Outline of Major Chapters:
Chapter 1: Introduces the definition of Healthcare Microfluidics, market overview.
Chapter 2: Global Healthcare Microfluidics market size in revenue and volume.
Chapter 3: Detailed analysis of Healthcare Microfluidics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Healthcare Microfluidics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Healthcare Microfluidics capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
